Zogenix, Inc. Raises $60 Million in Series A Venture Financing; Names Board of Directors
SAN DIEGO & HAYWARD, Calif.– –Aug. 28, 2006 – Zogenix, Inc., a privately held pharmaceutical company focused on medicines to treat CNS disorders and pain, today announced that the company has raised $60 …
Next Story: VenGrowth Funds successfully exit Quake Technologies investment following acquisition by AMCC
Previous Story: Roundup — PayPal's Thiel sued, Web 2.0 hitting wall, collective delusion & eBay strays on Yahoo
VB Writers
Ben PopperEast Coast Editor
Dean TakahashiLead Writer, GamesBeat
Devindra HardawarNational Editor, MobileBeat Lead
Dylan TweneyExecutive Editor
ShoeEditor-in-Chief, GamesBeat
Heather KellySenior Editor
Jennifer Van GroveWriter
Jolie O'DellWriter
Matt MarshallFounder & Editor-in-Chief
Meghan KellyWriter
Sarah MitroffEditorial Assistant
Sean LudwigWriter
Sebastian HaleyReviews Editor, GamesBeat
Tom CheredarWriter
Ciara ByrneContributor
Julia PlevinContributor
Lindsey ComptonContributor
